I. DURUR SUBAŞI Et Al. , "Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?," European Radiology Experimental , vol.5, no.1, 2021
DURUR SUBAŞI, I. Et Al. 2021. Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?. European Radiology Experimental , vol.5, no.1 .
DURUR SUBAŞI, I., Kose, D., Yayla, M., Sirin, B., KARAMAN, A., Calik, I., ... ALPER, F.(2021). Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?. European Radiology Experimental , vol.5, no.1.
DURUR SUBAŞI, Irmak Et Al. "Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?," European Radiology Experimental , vol.5, no.1, 2021
DURUR SUBAŞI, Irmak D. Et Al. "Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?." European Radiology Experimental , vol.5, no.1, 2021
DURUR SUBAŞI, I. Et Al. (2021) . "Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?." European Radiology Experimental , vol.5, no.1.
@article{article, author={Irmak DURUR SUBAŞI Et Al. }, title={Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?}, journal={European Radiology Experimental}, year=2021}